BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36425841)

  • 1. Management or technology? Firms' embeddedness in dual talent flow networks and their innovation performance.
    Sun B; Ruan A; Peng B; Liu S
    Front Psychol; 2022; 13():1028818. PubMed ID: 36425841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Talent Flow Network, the Life Cycle of Firms, and Their Innovations.
    Sun B; Ruan A; Peng B; Lu W
    Front Psychol; 2022; 13():788515. PubMed ID: 35668985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of network positions in scientific collaboration on pharmaceutical firms' technological innovation performance: Moderating roles of scientific collaboration strength and patent stock.
    Wang XX; Jiao HY
    Front Public Health; 2022; 10():980845. PubMed ID: 36033805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveiling the influence of global innovation networks on corporate innovation: evidence from the international semiconductor industry.
    Wu Y; Ding L; Li N; Yu X
    Sci Rep; 2024 May; 14(1):11007. PubMed ID: 38745006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How geopolitical risk affect firms' internationalization performance: Evidence from China.
    Guo J
    Heliyon; 2024 May; 10(9):e30152. PubMed ID: 38694047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of firm's feedbacks on user-generated content's linguistic style matching-An explanation based on communication accommodation theory.
    Liu D; Gong C; Zhang S; Ma Y
    Front Psychol; 2022; 13():949968. PubMed ID: 35936319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Firms' challenges and social responsibilities during Covid-19: A Twitter analysis.
    Patuelli A; Caldarelli G; Lattanzi N; Saracco F
    PLoS One; 2021; 16(7):e0254748. PubMed ID: 34314432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research on the impact of digital technology applications on firms' dual innovation in the digital economy context.
    Peiyao Q; Benrui C
    Sci Rep; 2024 Mar; 14(1):6415. PubMed ID: 38494534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of smart city pilots on corporate total factor productivity.
    Chen P
    Environ Sci Pollut Res Int; 2022 Nov; 29(55):83155-83168. PubMed ID: 35763146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of green credit policy on firms' green strategy choices: green innovation or green-washing?
    He L; Gan S; Zhong T
    Environ Sci Pollut Res Int; 2022 Oct; 29(48):73307-73325. PubMed ID: 35622278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does cooperation stimulate firms' eco-innovation? Firm-level evidence from China.
    Zhang S; Xu X; Wang F; Zhang J
    Environ Sci Pollut Res Int; 2022 Nov; 29(51):78052-78068. PubMed ID: 35689768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foreign executives, digital transformation, and innovation performance: Evidence from Chinese-listed firms.
    Shao D; Lv K; Fan X; Zhang B
    PLoS One; 2024; 19(6):e0305144. PubMed ID: 38848381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of smart manufacturing demonstration projects on green innovation of Chinese firms: Based on random forest methods.
    Yang J; Wang W; Fu C; Xu X; Li Q
    Heliyon; 2024 Apr; 10(7):e28925. PubMed ID: 38596016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Environmental regulation, firms' bargaining power, and firms' total factor productivity: evidence from China.
    Yang S; Wang C; Zhang H; Lu T; Yi Y
    Environ Sci Pollut Res Int; 2022 Feb; 29(6):9341-9353. PubMed ID: 34499302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unveiling the Effectiveness of Agency Cost and Firms' Size as Moderators Between CSR Disclosure and Firms' Growth.
    Akram A; Tang Y; Tariq J
    Front Psychol; 2020; 11():1624. PubMed ID: 32903572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Firm innovation activities and consumer brand loyalty: A path to business sustainability in Asia.
    Yi L; Khan MS; Safeer AA
    Front Psychol; 2022; 13():942048. PubMed ID: 35959050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.
    Fernald KD; Pennings HP; van den Bosch JF; Commandeur HR; Claassen E
    PLoS One; 2017; 12(2):e0172488. PubMed ID: 28231332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distance matters: Investigating how geographic proximity to ENGOs triggers green innovation of heavy-polluting firms in China.
    Hu C; Mao J; Tian M; Wei Y; Guo L; Wang Z
    J Environ Manage; 2021 Feb; 279():111542. PubMed ID: 33162234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does capital structure change product-market competitiveness? Evidence from Chinese firms.
    Li L; Wang Z
    PLoS One; 2019; 14(2):e0210618. PubMed ID: 30721237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Turning inward in difficulties: R&D human resource slack, technological diversification, and independent innovation.
    Li H; Zhao Y; Li Y; Wang Y
    PLoS One; 2024; 19(6):e0298453. PubMed ID: 38870238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.